follow
infect
genom
translat
positivestrand
rna
rna
virus
establish
cytoplasm
enzym
complex
direct
amplif
express
genom
viral
rnadepend
rna
polymeras
rdrp
central
enzym
replicationtranscript
complex
rtc
also
may
includ
viral
nonstructur
protein
nsp
host
factor
cooper
synthes
viral
rna
past
decad
becom
clear
rna
viru
rtc
invari
associ
virusinduc
membran
structur
poorli
character
presum
provid
framework
rna
synthesi
facilit
concentr
cooper
viral
macromolecul
dedic
membran
surfac
may
also
protect
viral
rna
nucleas
cytoplasm
host
cell
aid
shield
doublestrand
rna
intermedi
viru
replic
host
cell
innat
immun
system
contribut
coordin
viral
life
cycl
time
space
membranebound
rtc
molecular
machin
drive
rna
synthesi
evolut
rna
virus
clearli
unravel
structur
function
critic
understand
biochemistri
rna
viru
replic
develop
novel
antivir
control
strategi
rtc
coronavirus
includ
sarscoronaviru
sarscov
caus
agent
lifethreaten
sever
acut
respiratori
syndrom
review
see
refer
stand
number
reason
first
kb
polycistron
coronaviru
genom
far
largest
genom
among
current
known
rna
virus
second
viral
rnasynthes
machineri
amplifi
genom
also
direct
synthesi
set
subgenom
sg
mrna
eight
case
sarscov
express
viral
accessori
structur
protein
gene
latter
produc
correspond
set
subgenomelength
neg
strand
rna
deriv
discontinu
negativestrand
rna
synthesi
third
viral
replicasetranscriptas
refer
replicas
breviti
unpreced
size
complex
produc
translat
partli
overlap
open
read
frame
orf
express
latter
requir
ribosom
frameshift
near
end
manner
sarscov
genom
translat
yield
larg
replicas
polyprotein
aa
aa
extens
autoproteolyt
process
mediat
two
proteas
domain
ultim
gener
nsp
includ
key
replic
enzym
eg
varieti
subunit
contain
presum
accessori
function
viral
rna
synthesi
eg
nendou
sever
predict
multispan
membran
protein
presum
modifi
cellular
endomembran
target
rtc
scaffold
immunofluoresc
microscopi
previous
reveal
newli
synthes
sarscov
rna
sever
nsp
coloc
perinuclear
foci
sarscovinfect
cell
electron
microscopi
establish
presenc
typic
pair
membran
membran
whorl
doublemembran
vesicl
dmv
label
nsp
viral
rna
therefor
propos
carri
sarscov
rtc
endoplasm
reticulum
er
identifi
like
membran
donor
recent
electron
tomographi
studi
inde
reveal
network
sarscovinduc
membran
structur
continu
organel
knoop
et
al
prepar
past
four
year
substanti
progress
made
character
individu
replicas
subunit
use
enzymat
assay
revers
classic
genet
bioinformat
structur
studi
howev
composit
mechanist
nativ
ribonucleoprotein
complex
differ
compon
interact
drive
coronaviru
replic
transcript
remain
complet
uncharacter
thu
far
therefor
set
isol
activ
rtc
sarscovinfect
cell
use
develop
vitro
system
faith
reproduc
synthesi
genom
sg
rna
mainli
posit
polar
rtc
activ
cosedi
newli
synthes
viral
rna
sever
replicas
subunit
dens
membran
fraction
contain
structur
could
label
vitro
activ
pellet
rtc
depend
presenc
cytoplasm
host
factor
furthermor
rtc
activ
destroy
addit
nonion
deterg
also
releas
replicas
subunit
mainli
sg
rna
membran
fraction
proteas
nucleas
protect
experi
indic
viral
rna
nsp
protect
membran
thu
substanti
function
connect
sarscov
rna
synthesi
virusinduc
membran
structur
appear
essenti
rtc
activ
order
character
isol
sarscov
rtc
develop
vitro
rna
synthesi
assay
ivra
studi
activ
vitro
reaction
incorpor
ctp
viral
rna
analyz
mixtur
contain
ntp
atpregener
system
inhibitor
cellular
transcript
actinomycin
rtc
activ
cytoplasm
extract
prepar
sarscovinfect
cell
produc
set
rna
molecul
size
correspond
sarscov
genom
eight
sg
rna
fig
product
detect
use
mockinfect
cell
lysat
fig
mock
demonstr
sarscov
rtc
activ
respons
synthesi
reaction
condit
optim
vari
sever
paramet
includ
composit
reaction
mixtur
incub
time
temperatur
concentr
fig
data
shown
time
cours
experi
vitro
synthes
viral
rna
accumul
min
reaction
fig
decreas
observ
probabl
due
declin
rtc
activ
combin
continu
rna
degrad
cellular
nucleas
optim
reaction
temperatur
fig
rtc
activ
strongli
depend
concentr
maxim
mm
ad
reaction
fig
manganes
could
replac
ivra
contain
yield
ladder
small
radiolabel
rna
molecul
aberr
size
fig
suggest
effect
rdrp
process
addit
ionic
sd
deoxychol
doc
nonion
deterg
nonidet
triton
postnuclear
supernat
pn
prior
ivra
complet
abolish
accumul
radiolabel
viral
rna
suggest
integr
membran
import
factor
sarscov
rtc
activ
fig
determin
polar
vitro
produc
rna
product
ivra
hybrid
membran
contain
immobil
rna
probe
specif
sarscov
posit
negativestrand
rna
fig
strong
hybrid
posit
strandspecif
probe
observ
demonstr
rtc
mainli
synthes
rna
posit
polar
vitro
longer
exposur
time
small
quantiti
radiolabel
materi
hybrid
neg
strandspecif
probe
becam
visibl
similar
signal
observ
neg
control
rna
fig
indic
quantiti
vitro
synthes
negativestrand
rna
small
less
total
rna
line
larg
excess
posit
neg
strand
commonli
observ
vivo
assess
whether
protein
synthesi
occur
ivra
determin
whether
amino
acid
incorpor
protein
reaction
use
pn
uninfect
cell
sdspage
reveal
smear
materi
fig
lane
product
absent
pn
heat
min
prior
assay
fig
lane
suggest
result
translat
ivra
condit
use
pn
sarscovinfect
cell
observ
incorpor
radiolabel
also
set
discret
polypeptid
fig
lane
includ
speci
size
match
sarscov
membran
nucleocapsid
n
protein
like
due
fact
lysat
contain
larg
amount
sg
mrna
encod
protein
possibl
combin
virusinduc
shutoff
host
cell
translat
protein
synthesi
complet
inhibit
translat
inhibitor
cycloheximid
puromycin
present
ivra
fig
lane
affect
vitro
rtc
activ
sinc
quantiti
radiolabel
rna
product
unchang
fig
character
activ
rtc
pn
sarscovinfect
cell
subject
differenti
centrifug
supernat
fraction
show
rtc
activ
fig
lane
trace
amount
origin
activ
recov
pellet
fraction
fig
lane
surprisingli
rtc
activ
fraction
could
larg
restor
ad
aliquot
cytoplasm
fraction
fig
lane
fraction
prepar
mockinfect
cell
equal
capabl
restor
rtc
activ
indic
cytoplasm
host
factor
requir
fig
lane
routin
rtc
activ
origin
present
pn
could
recov
fraction
assay
supplement
remark
virtual
replic
activ
lost
transcript
decreas
fraction
deplet
host
factor
fig
lane
sediment
rtc
activ
suggest
associ
heavi
membran
structur
fraction
contain
bulk
rtc
activ
analyz
electron
microscopi
neg
stain
combin
immunogold
label
put
transmembran
protein
fig
data
shown
cluster
vesicl
diamet
nm
observ
appear
associ
tubular
flatten
membran
structur
strong
immunolabel
structur
sarscov
fig
fig
observ
membran
structur
immunoreact
fig
data
shown
detect
control
fraction
prepar
mockinfect
cell
occasion
doubl
membran
could
distinguish
fig
arrow
observ
consist
notion
fraction
enrich
sarscovinduc
nspcontain
membran
structur
document
infect
cell
distribut
newli
synthes
sarscov
rna
rtccontain
cytoplasm
fraction
analyz
fraction
pn
ivra
fig
bulk
newli
made
genom
rna
recov
fraction
suggest
remain
associ
heavi
membran
structur
contrast
newli
synthes
sg
rna
depend
size
progress
abund
suggest
releas
rtc
investig
role
membran
rna
local
ivra
perform
pn
ad
distribut
viral
rna
analyz
fig
bulk
smaller
rna
speci
recov
fraction
contrast
onehalf
genom
rna
remain
associ
fraction
deterg
treatment
suggest
productspecif
differ
rtc
oper
organ
appear
includ
partli
detergentresist
structur
select
nsp
suitabl
antisera
reactiv
western
blot
experi
avail
distribut
cytoplasm
fraction
rtccontain
fraction
analyz
reveal
rtc
subunit
enrich
mainli
present
fraction
fig
bulk
fraction
found
almost
exclus
fraction
fig
lane
detect
fraction
although
also
substanti
amount
found
cytoplasm
fraction
fig
lane
treatment
pn
prior
fraction
led
redistribut
longer
found
fraction
recov
increas
level
fraction
fig
lane
suggest
direct
indirect
associ
membran
caus
cosedi
rtc
activ
fraction
assess
role
membran
sarscov
rna
synthesi
investig
whether
protect
rtc
standard
ivra
perform
follow
treatment
nucleas
nonspecif
nucleas
degrad
singl
doublestrand
rna
presenc
absenc
fraction
sampl
quantiti
vitro
synthes
radiolabel
rna
fraction
analyz
fig
untreat
control
sampl
newli
made
viral
rna
found
associ
rtc
fraction
predominantli
genom
rna
well
releas
cytoplasm
fraction
enrich
sg
rna
fig
lane
newli
made
viral
rna
cytoplasm
complet
degrad
upon
nucleas
treatment
fig
lane
rna
associ
rtc
protect
fig
lane
latter
product
becam
suscept
nucleas
treatment
upon
addit
suggest
replic
rna
enclos
membran
fig
compar
lane
determin
whether
also
replicas
subunit
protect
membran
pn
treat
proteinas
k
either
absenc
presenc
proteasetr
sampl
untreat
control
subsequ
fraction
presenc
probe
western
blot
fig
cytoplasm
pellet
suscept
proteas
treatment
fig
top
panel
subunit
mainli
cosedi
rtc
larg
resist
proteas
treatment
fig
middl
panel
lane
degrad
presenc
observ
proteaseresist
due
lack
proteinas
k
activ
sinc
host
protein
crossreact
antiserum
complet
degrad
sampl
likewis
fraction
resist
proteas
treatment
surprisingli
also
true
present
fraction
fig
lower
panel
form
suscept
proteas
presenc
nonion
deterg
data
suggest
enclos
membran
agreement
membran
topolog
predict
domain
use
rais
antiserum
major
part
expos
surfac
membran
structur
sarscov
rtc
like
rtc
rna
virus
believ
associ
virusinduc
structur
deriv
intracellular
membran
coronaviru
rtc
compos
unusu
larg
number
subunit
includ
sever
nsp
uniqu
enzym
function
despit
steadi
progress
function
character
sarscov
nsp
includ
rdrp
helicas
enzym
central
replic
still
earli
stage
investig
detail
molecular
interplay
subunit
viral
rna
templat
host
factor
vitro
assay
viral
rna
synthesi
indispens
solubl
express
purif
sever
individu
coronaviru
nsp
proven
problemat
combin
membraneassoci
natur
complex
suggest
reconstitut
rtc
purifi
compon
remain
distant
perspect
complementari
approach
therefor
set
isol
activ
sarscov
rtc
current
avail
sourc
virusinfect
cell
newli
develop
ivra
describ
paper
fig
allow
us
obtain
insight
architectur
function
sarscov
rtc
whole
may
aid
address
poorli
defin
role
cellular
membran
although
rdrp
activ
cell
lysat
previous
report
coronavirus
mous
hepat
viru
transmiss
gastroenter
viru
knowledg
first
descript
robust
vitro
system
coronaviru
rna
synthesi
produc
full
spectrum
viral
mrna
genom
sg
rna
gener
infect
cell
similar
vitro
system
recent
develop
distantli
relat
arteriviru
equin
arter
viru
manuscript
prepar
suggest
method
may
gener
applic
nidoviru
rtc
protein
synthesi
occur
lysat
ivra
condit
use
inhibit
affect
vitro
rtc
activ
fig
suggest
contrast
describ
cell
infect
mous
hepat
viru
sarscov
unpublish
data
continu
translat
requir
rtc
activ
vitro
like
inhibit
protein
synthesi
influenc
activ
preform
activ
rtc
present
pn
mainli
synthes
rna
posit
polar
fig
current
suitabl
small
sarscov
rna
replicon
could
ad
ivra
exogen
templat
distinguish
natur
viral
rna
basi
size
avail
consequ
address
question
whether
de
novo
initi
rna
synthesi
occur
system
must
wait
technic
advanc
area
made
still
potenti
complic
may
inabl
exogen
templat
enter
membraneprotect
rtc
also
observ
studi
molecul
like
nucleas
proteinas
k
fig
sarscov
rtc
activ
recov
heavi
membran
pellet
isol
rtc
supplement
fraction
infect
uninfect
cell
regain
activ
fig
indic
besid
host
factor
possibl
associ
rtc
fraction
also
cytoplasm
host
factor
requir
sarscov
rna
synthesi
natur
host
factor
current
analyz
replic
appear
particularli
depend
presenc
host
factor
transcript
reduc
replic
bare
detect
fraction
deplet
host
factor
fig
whether
differ
mere
due
larger
size
genom
rna
andor
reflect
higher
demand
specif
role
host
factor
replic
remain
investig
detail
rtc
activ
cosedi
newli
synthes
viral
rna
sever
replicas
subunit
membran
structur
latter
protein
put
multispan
transmembran
protein
presum
import
induct
rtcrelat
membran
rearrang
accompani
sarscov
infect
furthermor
cosediment
rtc
fig
may
indic
one
multipl
enzymat
activ
multidomain
protein
import
rna
synthesi
main
proteinas
copurifi
rtc
activ
fraction
although
remain
investig
whether
find
directli
relat
site
replicas
polyprotein
process
rtc
core
enzym
postul
work
concert
uniqu
second
rdrp
activ
recent
identifi
propos
rna
primas
activ
would
consist
partial
cosediment
rtc
observ
studi
fig
treatment
longer
cosedi
suggest
releas
membran
structur
addit
proteas
protect
experi
absenc
presenc
deterg
reveal
part
shield
membran
predict
cytoplasm
domain
experi
fig
indic
cytoplasm
form
also
shield
proteas
activ
membran
suggest
exist
membran
structur
distinct
rtccontain
complex
cosediment
rtc
activ
line
coloc
specif
structur
perinuclear
region
sarscovinfect
cell
observ
immunofluoresc
microscopi
free
rna
transmiss
gastroenter
viru
previous
found
suscept
nucleas
treatment
wherea
negativestrand
rna
small
fraction
probabl
nascent
positivestrand
rna
present
membraneprotect
complex
studi
nonion
deterg
render
sarscov
rna
suscept
nucleas
digest
fig
destroy
rtc
activ
fig
signifi
import
intact
membran
structur
viral
rna
synthesi
disrupt
may
dissoci
activ
enzym
complex
andor
chang
rtc
microenviron
may
provid
access
cytoplasm
nucleas
bulk
newli
synthes
sarscov
genom
remain
associ
rtccontain
heavi
membran
structur
sg
rna
appear
readili
releas
structur
synthes
previou
studi
transmiss
gastroenter
viru
also
found
preferenti
sg
rna
longer
associ
membraneassoci
complex
releas
rna
molecul
might
repres
pool
mrna
destin
translat
structur
accessori
protein
sg
rna
addit
replicas
protein
rtcassoci
rna
might
engag
replic
andor
packag
manner
intracellular
compartment
mediat
format
special
membran
structur
might
also
serv
coordin
differ
step
viral
life
cycl
andor
enhanc
specif
viral
rna
surprisingli
treatment
larg
fraction
genom
rna
remain
pellet
suggest
associ
detergentresist
structur
might
indic
postul
hepat
c
viru
replic
complex
sarscov
rtc
associ
lipid
raft
lipid
droplet
featur
could
also
explain
propos
role
lipid
raft
earli
stage
sarscov
replic
sarscov
rtc
studi
suggest
enclos
membran
may
provid
optim
environ
viral
rna
synthesi
rais
question
newli
synthes
rna
product
releas
structur
moreov
fact
rtc
activ
depend
cytoplasm
host
factor
cosedi
complex
addit
indic
crosstalk
cytoplasm
rtccontain
membran
structur
must
occur
eg
via
channel
may
facilit
transport
across
membran
taken
togeth
data
support
exist
function
link
sarscov
rna
synthesi
unusu
membran
structur
induc
upon
coronaviru
infect
cell
infect
sarscov
strain
frankfurt
multipl
infect
describ
previous
procedur
involv
live
sarscov
perform
biosafeti
level
facil
leiden
univers
medic
center
rabbit
antisera
recogn
describ
previous
antisera
rais
new
zealand
white
rabbit
use
antigen
bovin
serum
albumincoupl
synthet
peptid
fsnsgadvlyqppqtsitsavlq
lnikllgiggkpcikvatvq
repres
ctermin
sequenc
respect
sarscov
mockinfect
cell
eight
flask
harvest
trypsin
hour
post
infect
inhibit
cellular
transcript
actinomycin
present
solut
use
harvest
wash
cell
wash
pb
cell
resuspend
ml
icecold
hypoton
buffer
mm
hepe
mm
kcl
mm
mm
dtt
uml
rnaseout
invitrogen
actinomycin
ph
incub
min
cell
disrupt
use
dounc
homogen
give
stroke
tight
fit
pestl
isoton
condit
restor
ad
hepe
sucros
dtt
result
final
lysat
contain
mm
hepe
ph
mm
sucros
mm
kcl
mm
dtt
mm
actinomycin
uml
rnaseout
nuclei
larg
debri
remain
intact
cell
remov
two
success
centrifug
result
pn
either
assay
immedi
rtc
activ
store
sarscov
titer
present
pn
approxim
plaqueform
unit
per
ml
plaqu
assay
perform
ivra
reveal
measur
de
novo
viru
product
occur
assay
data
shown
pellet
supernat
fraction
prepar
pn
centrifug
min
pellet
resuspend
dilut
buffer
mm
hepe
mm
sucros
mm
kcl
mm
dtt
mm
ph
origin
pn
volum
pellet
prepar
experi
pn
incub
min
prior
prepar
fraction
assay
perform
use
either
pn
supplement
requir
total
volum
adjust
dilut
buffer
subsequ
addit
reaction
compon
yield
final
reaction
volum
contain
mm
hepe
ph
mm
sucros
mm
kcl
mm
dtt
mm
actinomycin
u
rnaseout
mm
creatin
phosphat
sigma
uml
creatin
phosphokinas
sigma
mm
atp
mm
gtp
mm
utp
ctp
ctp
ge
healthcar
unless
otherwis
indic
ivra
perform
min
reaction
termin
ad
mixtur
contain
lithium
dodecyl
sulfat
trishcl
ph
licl
mm
edta
mm
dtt
mgml
proteinas
k
incub
min
protein
synthesi
test
ctp
replac
promix
ge
healthcar
contain
mixtur
methionin
cystein
assess
effect
translat
inhibit
cycloheximid
puromycin
ad
rna
isol
ivra
reaction
mixtur
acid
phenol
extract
isopropanol
precipit
reaction
product
analyz
denatur
formaldehyd
agaros
gel
electrophoresi
essenti
describ
previous
except
agaros
gel
use
radiolabel
vitro
synthes
rna
detect
expos
phosphorimag
screen
directli
dri
gel
screen
scan
person
molecular
imag
fx
biorad
data
analyz
quantiti
one
version
biorad
unlabel
endogen
sarscov
rna
detect
hybrid
oligonucleotid
complementari
sequenc
present
sarscov
rna
vitro
transcrib
rna
correspond
nt
region
complementari
nt
sarscov
genom
immobil
hybond
n
membran
ge
healthcar
neg
control
rna
correspond
nt
ctrl
equin
arter
viru
genom
complementari
sequenc
ctrl
b
includ
membran
immobil
probe
prehybrid
hour
hybrid
mixtur
contain
mm
nacl
mm
mm
edta
ph
sd
denhardt
homomix
subsequ
membran
hybrid
half
rna
recov
ivra
ml
hybrid
mix
first
heat
denatur
min
hybrid
h
membran
wash
twice
min
ml
sspe
sd
hybrid
signal
quantifi
phosphorimag
analysi
protein
separ
sdspage
transfer
hybondp
pvdf
membran
ge
healthcar
semidri
blot
block
casein
pb
contain
pbst
membran
incub
rabbit
antisera
dilut
pbst
casein
bsa
peroxidaseconjug
swine
antirabbit
igg
antibodi
dako
eclplu
kit
ge
healthcar
use
detect
proteas
protect
experi
done
incub
pn
min
proteinas
k
either
absenc
presenc
inactiv
proteas
addit
mm
pmsf
fraction
pellet
supernat
sampl
analyz
western
blot
nucleas
protect
assay
standard
ivra
perform
pn
nucleas
ad
either
presenc
absenc
incub
sampl
fraction
fraction
radiolabel
rna
isol
fraction
analyz
describ
one
volum
paraformaldehyd
mm
pipe
mm
hepe
mm
mm
egta
ph
ad
fraction
formvarco
grid
place
drop
fix
fraction
incub
room
temperatur
min
block
bsa
pb
grid
incub
min
rabbit
antisera
direct
pb
contain
bsa
bound
rabbit
igg
detect
protein
carri
gold
particl
neg
stain
phosphotungst
acid
grid
view
fei
transmiss
electron
microscop
kv
